16. Fineman MS, Bicsak TA, Shen LZ, Taylor K, Gaines E, Varns A, Kim D, Baron AD:Effect on glycemic control of exenatide(synthetic exendin-4) additive to existingmetformin and/or sulfonylurea treatmentin patients with type 2 diabetes. Diabetes Care 26:2370–2377, 2003 17. Nielsen LL, Baron AD: Pharmacology of exenatide (synthetic exendin-4) for thetreatment of type 2 diabetes. Curr Opinion Investig Drugs 4:401–405, 2003 18. Nielsen LL, Young AA, Parkes D: Pharma- cology of exenatide (synthetic exendin-4): a potential therapeutic for improvedglycemic control of type 2 diabetes. Regul Pept117:77–88, 2004 19. Holst JJ, Gromada J: Role of incretin hor- mones in the regulation of insulin secre-tion in diabetic and nondiabetic humans.Am J Physiol Endocrinol Metab 287:E199– E206, 2004 20. World Medical Association Declaration of Helsinski: Recommendations guidingphysicians in biomedical research involv-ing human subjects (Letter). JAMA 277: 925–926, 1997